Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF JUNE 30,1995 PSA#1379

GSA, PBS, Fee Developer (WPCA),Procurement Br, Room 2634,7th & D Streets, SW,Washington,DC 20407

C -- NIH CLINICAL COMPLEX DEVELOPER A-E SOL GS-11P-95-AQC-0018 DUE 081495 POC Contact,Christine S. Kelly,202/708-4900,Contracting Officer,William B. Owen by,202/708-8905 The General Services Administration (GSA) and the National Institutes of Health (NIH) announce an opportunity for design excellence in public architecture. A-E Services are required for renewal of the main biomedical research facility on NIH's campus in Bethesda, Maryland. The government intends to contract with a private developer for development management and other services. Included in the Developers contract is complete A-E design services with the ''A-E design firm'' that best demonstrates a commitment to overall(functional & aesthetic) design excellence, while providing a viable team organization meeting the limitations set forth in this announcement. An ''A-E Design Firm'' is defined as the A-E firm, partnership, corporation, joint venture or other legal entity which shall have contractual responsibility for the project design and production. The program objectives for this project are to 1)serve the Government's needs for functional space that is adaptable/flexible, efficient, readily maintained, cost effective, and is supported by state-of-the-art infrastructure systems; 2)provide a visual testimony to the scientific integrity and public accountability in the conduct of science; and 3)facilitate NIH's overall mission with a structure which shall serve as an asset to both the NIH campus and neighboring communities. The primary clinical research facility of the NIH, known as the Clinical Center Complex (CCC), includes extensive clinical areas, 450 inpatient beds, biomedical research laboratories, vivarium facilities, support services, administrative offices, public spaces and parking. The renewal of the CCC includes the initial replacement of the present clinical care units with a flexible and adaptable 78,965 sq. meter (850,000 GSF) clinical research facility. The new facility will contain 250 inpatient beds, approximately 100 day hospital units, some support services, and associated biomedical research laboratories. The new facility will be operationally integrated with and physically linked to the existing complex. The estimated construction cost range of this facility is $300-$360 million. The scope of the A-E services may include, but not be limited to, the following: pre-design programming, site investigation, complete design services, computer aided design and drafting (CADD), working drawings, specifications, cost estimating, space planning, exterior and landscaped design, interior design, value engineering services, post construction contract services, and other required supplemental services if so requested. The facility will be designed in metric units. The Government intends to procure a Development Manager who will contract with the selected A-E Firm. The selection process will be conducted in two stages as follows: STAGE I: The first stage will establish the design excellence capabilities of the A-E Design Firm and its designated lead designer. The ''Lead Designer'' is defined as the design studio or individual who shall have the primary responsibility to conceive the design concept and the building's architecture. This studio or individual will be employed (on the payroll - non-contract) by the A-E Design Firm and clearly identified. The A-E design firm will provide specific evidence of its capabilities to deliver Design Excellence, which respond to the client's programmatic, operational and contextual requirements, and will clearly express its design approach and philosophy. If the A-E design firm is a partnership, corporation, joint venture, or other legal entity permitted by law to practice architecture or engineering, briefly describe the proposed working and legal relationships among its components. In the first stage, a short list minimum of at least three(3) ''A-E Design Firms'' will be selected for the project. This short list will be based on the ''A-E Design Firms'' submittals of the SF255 design portfolio and applicable SF254s (dated within the last 12 months from the due date in this synopsis) in response to this Request for Qualifications(RFQ). The A-E Design Firm will provide specific evidence of its capabilities to deliver Design Excellence in Architectural Design and will express its design approach and philosophy. Qualifications submitted will be reviewed and evaluated based on the following CRITERIA: (1) Past Performance on Design (50%): For the ''A-E design firm'', submit graphics (maximum of three 8 X 11 pages per project) and a typewr itten description (maximum of two pages per project) of not more than five projects completed in the last ten years. The narrative shall address the design approach with salient features for each project and discuss how the client's program, functional, image, mission, economic, schedule, and operational objectives were satisfied by the overall design/planning solution. Include tangible evidence where possible such as certificates, awards, peer recognition, etc., demonstrating design excellence. Provide a client reference contract for each project, including name, title, address, phone, and fax numbers. A portion of one page, presented for each project must include a representative floor plan and either a site plan or a building section. One project must present a new facility that is either healthcare, research or other type of high-tech complex. The high-tech project that is presented must be situated in either an urban or campus setting. Another project must present a new facility that is related to or linked with an existing facility. (2) Philosophy and Design Intent (30%): In the Lead Designer's words, (maximum of two typewritten pages) state his/her overall design philosophy, approach to the challenge of resolving design issues and parameters that apply specifically to the proposed NIH project with focus on any unique aspects of relating NIH's proposed facility back to the existing complex and its relationship to the existing Bethesda campus. Provide a brief summary conclusion. (3) Lead Designer Portfolio/Profile (20%): Submit graphics (maximum of three 8 X 11 pages per project) and a typewritten description (maximum of one page per project) of not more than three designs completed in the last ten years attributed to the lead designer. Narratives will include a discussion of design challenges and resolutions. Provide a client reference contact for each project, including name, title, address, phone, and fax numbers. Submit biographical sketch including education, professional experience, and recognition for design efforts inclusive of examples. Identify and describe areas of responsibility and commitment to this project. STAGE II: In this stage, the short-listed A-E design firms will provide a more detailed qualifications submittal, participate in a conceptual design competition and be interviewed with their entire team. A stipend shall be provided to the teams to compensate partial costs incurred during the Stage II competition. The entire project team, A-E design firm, lead designer and all consultants who will work on the project will be evaluated by the Development Manager and the Government. The A-E Design firms will submit Standard Forms 254 and 255 that reflect the entire project team. Information submitted in Stage I does not have to be resubmitted. The Development Manager and the Government will establish the criteria and the date these submittals are due and provide the selection criteria for interviews, Stage II conceptual design competition, and final selection process, with the Stage I short list announcement, published in the CBD. Sufficient time will be provided for the A-E design firm to establish its complete team of consultants. The selected A-E firm shall establish a local presence, dedicated to this project, within the Washington, D.C. metro area within sixty days of contract signature. FOR STAGE I SUBMITTALS: Firms having the capabilities to perform the services described in this announcement are invited to respond by submitting a letter of interest and SIX (6) copies of the Stage I submittal information listed above TO: General Services Administration, 7th & D Streets, SW, Washington, DC 20407 by 3:30 p.m. local time on the DUE date of this notice. The following information MUST be on the outside of the sealed envelop: 1) Solicitation Number/Title 2) Due Date 3) Closing Time. Late responses are subject to FAR Provision 52.215.10. In Block 8 of the SF254 specify only current W-2 payroll personnel (non-contract) of each firm. In Block 10 of the SF255 the A-E Design firm must respond to the three (3) EVALUATION CRITERIA stated in this announcement for Stage I. In Block 11 of the SF 255, the A-E Design Firm must sign, name, title and date of the submittal. Small and minority-owned A-E firms are encouraged to participate. The Government recognizes the talent existing in smaller firms and encourages the contributions of new and innovative designers to public architecture. There will be a pre-submission meeting on July 17, 1995 at 2:00 at the Masur Auditorium in the NIH Clinical Center (Building 10) at Bethesda, Maryland. This solicitation is opened internationally to firms registered to practice architecture in the United States. This is not a request for proposals (RFP). (0179)

Loren Data Corp. http://www.ld.com (SYN# 0024 19950629\C-0012.SOL)


C - Architect and Engineering Services - Construction Index Page